BioLineRx Ltd. (NASDAQ:BLRX) Q2 2021 Earnings Conference Call August 18, 2021 10:00 AM ET
Company Participants
Tim McCarthy - LifeSci Advisors, IR
Philip Serlin - Chief Executive Officer
Mali Zeevi - Chief Financial Officer
Abi Vainstein-Haras - Chief Medical Officer
Ella Sorani - Chief Development Officer
Conference Call Participants
Joe Pantginis - HC Wainwright
Mark Breidenbach - Oppenheimer
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2021 Results Conference Call. All participants are presently in a listen-only mode. Following management’s formal presentation, instructions will be given for the question-and-answer session [Operator Instruction]
I would now like to turn over the call to Tim McCarthy of LifeSci Advisors. Please go ahead.
Tim McCarthy
Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements in this conference call other than historical facts are indeed forward-looking statements. The words anticipate, believe, estimate, expect, intend, guidance, confidence, target, project and other similar expressions are used typically to identify such forward-looking statements.
These forward-looking statements are not guarantees of future performance and may involve and are subject to certain risks and uncertainties and other factors that may affect BioLineRx’s business, financial condition and other operating results.
These include, but are not limited to, the risk factors and other qualifications contained in BioLineRx’s annual report on Form 20-F, quarterly reports filed in the 6-K and other reports filed by BioLineRx with the SEC to which your attention is directed. Actual outcomes and results may differ materially from what is expressed or implied by these forward-looking statements. BioLineRx expressly disclaims any intent or obligation to update these forward-looking statements.
At this time, it is now my pleasure to turn the call over to Mr. Phil Serlin, Chief Executive Officer of
- Read more current BLRX analysis and news
- View all earnings call transcripts